Details for 2018881166
Up to date per 03.04.2026
Actions
Details for 2018881166
Granted/Registered
European Patent
07.10.2020 A
08.03.2023 B1
27.11.2017
US
201762590976 P
30.04.2018
US
201862664726 P
C12N 7/00 20060101AFI20210805BHEP
Owner
4D Molecular Therapeutics Inc.5980 Horton Street Suite 460 Emeryville, CA 94608US
Representative
No representatives present
Inventor
KIRN, David5980 Horton Street Suite 460 Emeryville, California 94608US
KOTTERMAN, Melissa5980 Horton Street Suite 460 Emeryville, California 94608US
SCHAFFER, David5980 Horton Street Suite 460 Emeryville, California 94608US
SZYMANSKI, Paul5980 Horton Street Suite 460 Emeryville, California 94608US
FRANCIS, Peter5980 Horton Street Suite 460 Emeryville, California 94608US
Information about Fees